2m 2m 2m 2m 2m 2m 2m
TANDEM DIABETES (TNDM)
NASDAQ
$19.60+$0.10 (+0.52%)
Price as of Aug 03, 2026 8:36 AM EDT- $1.3BMarket Cap
- 26.62%1-Year Change
- Medical DevicesIndustry
TANDEM DIABETES (TNDM)
$19.60+$0.10 (+0.52%)
TNDM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.50 | ||
Change | +$0.49 (+2.58%) | ||
Open | $19.10 | ||
High | $19.66 | ||
Low | $18.56 | ||
Previous Close | $19.01 | ||
Volume | 1,833,988 | ||
30-Day Average Volume | 1,639,928 | ||
1-Week Change | 13.90% | ||
1-Month Change | 29.22% | ||
1-Year Change | 26.62% | ||
3-Year Change | -44.16% | ||
5-Year Change | -82.06% | ||
Fundamentals | |||
Shares Outstanding | 68.5M | ||
Total Assets | $1.2B | ||
Market Cap | $1.3B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $247.2M | ||
Net Income | -$20.4M | ||
Free Cash Flow | $4.8M | ||
EBIT | -$18.1M | ||
EBITDA | -$13.6M | ||
Net Working Capital | $639.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -129 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 10 | ||
P/E | -65 | ||
PEG | 0 | ||
Price/Free Cash Flow | 279 | ||
Price/Operating Cash Flow | 121 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 10/10/2017 | ||
Earnings & Revenue